| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI117085 |
| P8608 | Fatcat ID | release_7gdupj6355evpcwkihaaoym4qy |
| P932 | PMC publication ID | 294083 |
| P698 | PubMed publication ID | 8132769 |
| P2093 | author name string | Oksenhendler E | |
| Ferchal F | |||
| Ngo-Giang-Huong N | |||
| Langlade-Demoyen P | |||
| P2860 | cites work | Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia | Q27861076 |
| Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition | Q28282470 | ||
| Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. | Q36641930 | ||
| Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro | Q36687926 | ||
| An idiotypic network model of AIDS immunopathogenesis | Q37475372 | ||
| Lack of evidence of prolonged human immunodeficiency virus infection before antibody seroconversion | Q38535205 | ||
| AIDS virus-specific cytotoxic T lymphocytes in lung disorders | Q41447927 | ||
| Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. | Q43616897 | ||
| The effect of fresh lymphocytes on increased sensitivity of HIV-1 isolation: a multicenter study | Q43666276 | ||
| Plasma viraemia in seronegative HIV-1-infected individuals | Q43862874 | ||
| HIV-1 in seronegative homosexual men. | Q44355795 | ||
| HIV isolation and antigen detection in infected individuals and their seronegative sexual partners. | Q44662497 | ||
| Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes | Q44758112 | ||
| Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection | Q45839889 | ||
| Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods | Q45843610 | ||
| Duration of human immunodeficiency virus infection before detection of antibody | Q45844568 | ||
| Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection | Q45848974 | ||
| Prevalence of HIV infection in seronegative high-risk individuals examined by virus isolation and PCR. | Q45860446 | ||
| Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. | Q45868316 | ||
| Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population | Q45871125 | ||
| Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers | Q45872719 | ||
| Assessment by gene amplification and serological markers of transmission of HIV-1 from hemophiliacs to their sexual partners and secondarily to their children | Q45883413 | ||
| Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs | Q45885787 | ||
| DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals. | Q53766998 | ||
| HIV and HLA similarity | Q58986003 | ||
| In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specificin vitro reactivity | Q63707151 | ||
| DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells | Q64130379 | ||
| Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain | Q68085411 | ||
| Polymerase chain reaction testing of HIV-1 seronegative at-risk individuals | Q68088932 | ||
| Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans | Q69050654 | ||
| HIV revealed: toward a natural history of the infection | Q69388232 | ||
| Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice | Q69541342 | ||
| Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridisation to amplified viral DNA | Q69922355 | ||
| Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction | Q69923085 | ||
| HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant | Q72214875 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| cytotoxicity | Q246181 | ||
| P304 | page(s) | 1293-1297 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients | |
| P478 | volume | 93 |
| Q45867374 | 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine |
| Q35868324 | A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. |
| Q35635272 | A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production |
| Q36380434 | Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele |
| Q74598024 | Attempt to modify the immune response developed against FIV gp120 protein by preliminary FIV DNA injection |
| Q53925928 | CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. |
| Q41649672 | CD8+ cell-mediated immune responses: relation to disease resistance and susceptibility in lentivirus-infected primates |
| Q41610140 | CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. |
| Q71803126 | CTL to HIV-1: Surrogates or sirens |
| Q37596619 | Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients |
| Q40527571 | Cellular immunity and a type 1 cytokine profile in protection against HIV infection and progression to AIDS. |
| Q35920663 | Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy |
| Q37344616 | Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure |
| Q40857790 | Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications. |
| Q35898707 | Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development |
| Q34194927 | Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina |
| Q73619641 | DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity |
| Q44895700 | DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector |
| Q40777827 | Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation |
| Q35865606 | Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination. |
| Q36370382 | Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes |
| Q41188781 | Do cytotoxic T lymphocytes clear some HIV/SIV infections? |
| Q24682788 | ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids |
| Q37902370 | Effect of multiple infection of cells on the evolutionary dynamics of HIV in vivo: implications for host adaptation mechanisms |
| Q33806715 | Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway |
| Q47582681 | Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates |
| Q33822789 | Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. |
| Q24815966 | Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera |
| Q36575290 | Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection |
| Q39470615 | Frequency of the delta ccr5 deletion allele in the urban Brazilian population |
| Q57997576 | Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers |
| Q36875347 | Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacity |
| Q36342033 | Global human genetics of HIV-1 infection and China |
| Q39806672 | HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase |
| Q33538666 | HIV pathogenesis: mechanisms of susceptibility and disease progression |
| Q73085652 | HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine |
| Q44139088 | HIV-1-specific cellular immune responses among HIV-1-resistant sex workers |
| Q59661551 | HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia |
| Q28291024 | HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women |
| Q57997711 | HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals |
| Q54115165 | HLA antigens associated with susceptibility/resistance to HIV-1 infection. |
| Q35576894 | Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection |
| Q29614956 | Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection |
| Q24531918 | Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries |
| Q43825794 | Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau |
| Q34461381 | Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero |
| Q37511451 | Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag. |
| Q45736750 | Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus. |
| Q44624519 | IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine |
| Q40422647 | Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601. |
| Q45094092 | Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules |
| Q59706065 | Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons |
| Q45752434 | Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood |
| Q34129921 | Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance? |
| Q36876711 | Immunogenetics: Genome-Wide Association of Non-Progressive HIV and Viral Load Control: HLA Genes and Beyond |
| Q45745969 | Immunomodulatory effect of a plasmid expressing CD40 ligand on DNA vaccination against human immunodeficiency virus type-1. |
| Q45764135 | Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen |
| Q40633155 | Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTL |
| Q54492375 | Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag. |
| Q35895851 | Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. |
| Q33808351 | Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes |
| Q34949513 | Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response |
| Q90401731 | Large-Scale "OMICS" Studies to Explore the Physiopatholgy of HIV-1 Infection |
| Q36010671 | Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses |
| Q36484055 | Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory act |
| Q40947468 | Long-term survivors of HIV-1 infection |
| Q45737944 | Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes |
| Q36598618 | Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells |
| Q41413187 | Mechanisms of resistance to HIV infection |
| Q39682548 | Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes |
| Q34996361 | Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals |
| Q40662796 | Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection |
| Q30404569 | Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants |
| Q37365402 | Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners |
| Q37145259 | Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infection |
| Q33968779 | Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge. |
| Q35887675 | Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. |
| Q36410459 | Protective immunity against hepatitis C virus infection |
| Q37050078 | Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals |
| Q28362322 | Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission |
| Q41212897 | Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure |
| Q28296715 | Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya |
| Q33961883 | Risk and management of blood-borne infections in health care workers |
| Q58328348 | Role of Cellular Immunity in Protection against HIV Infection**This article was accepted for publication on 31 October 1996 |
| Q34069815 | Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. |
| Q33808774 | Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus |
| Q35881271 | Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms |
| Q24670153 | Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization |
| Q33797324 | The effect of viruses on the ability to present antigens via the major histocompatibility complex |
| Q44439324 | The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design |
| Q36415776 | Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals. |
| Q36181264 | Vaccine strategies for infectious diseases |
| Q73566301 | Zinc-controlled Th1/Th2 switch significantly determines development of diseases |
Search more.